PHAT · Phathom Pharmaceuticals, Inc. · Debt

$5.74 -1.27 (-18.12%) At close · Oct 23

Market Cap

$464.37M

80.90M

Volume · Oct 23 4.87M Avg daily vol (3M) 1.45M

Debt Profile

Completed filing coverage through Dec 14, 2023

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Long-term debt, including current maturities	2026-06-30	USD 164,587,000	10-Q filed 2026-07-30
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of long-term debt USD 0 Noncurrent debt carrying amount USD 164,587,000
Operating lease liabilities	2026-06-30	USD 2,525,000	10-Q filed 2026-07-30
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 670,000 Noncurrent operating lease liabilities USD 1,855,000

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1783183 CUSIP 71722W107 13F (30d) 16 filings 16 filers Visit website Investor relations